Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$23.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Read More This medicine is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. If you are experiencing a medical emergency, please call your doctor ( truth or complete healthcare information ) or get medical professional help at. If this book contains graphic images of products then please contact "641-843-4745".Read More HealthylifeHealthylife is a brand of ciprofloxacin sold by Healthylife, a leading supplier of generic ciprofloxacin, a powerful broad spectrum antibiotic belonging to the fluoroquinolone family. Generic ciprofloxacin is supplied in multiple strengths, including 500mg, 750mg, and 10mg tablets. Generic ciprofloxacin is only available as a 500mg strength, but the generic is sold in various strengths, including 10mg and 20mg tablets. Generic ciprofloxacin is a broad spectrum antibiotic belonging to the fluoroquinolone family. Ciprofloxacin is used to treat a variety of bacterial infections, including skin and soft tissue infections, urinary tract infections, and respiratory tract infections. The generic ciprofloxacin is only available as a 10mg strength and can only be obtained with a valid prescription from your healthcare provider. Generic ciprofloxacin is a powerful antibiotic that works by inhibiting bacterial DNA gyrase, an enzyme vital for DNA replication and transcription. This prevents the bacteria from multiplying, ultimately killing the infection. Ciprofloxacin is effective in treating a variety of bacterial infections, including skin and soft tissue infections, urinary tract infections, and respiratory tract infections. The antibiotic can be used to treat infections caused by susceptible strains of bacteria, such as Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, and Enterobacter species. The antibiotic can also be used to treat other types of bacterial infections, such as sinusitis and otitis media. The active ingredient of Ciprofloxacin is ciprofloxacin, which is an antibiotic that works by inhibiting the growth of bacteria. Ciprofloxacin is effective against a wide range of bacterial infections, including sinusitis, otitis media, and pneumonia. The antibiotic can be used to treat bacterial infections such as pneumonia, bronchitis, pneumonia, nosocomial pneumonia, and community-acquired pneumonia. Ciprofloxacin is also effective against certain sexually transmitted infections, such as gonorrhea and syphilis. Ciprofloxacin is also effective against certain types of pneumonia in women and children. The antibiotic can also be used to treat uncomplicated genital tract infections, such as cystitis, infected genital ulcers, and prostatitis. Ciprofloxacin is also effective in treating infections caused by bacteria that are not inhibited by steroids. Ciprofloxacin is usually taken as a single daily dose, usually twice a day. Read more Read More Healthylife has made it possible to order this medicine from Bazaar-voice. Bazaar-voice. Healthylife has made it possible to order this medicine from Bazaar-voice. Contact your local pharmacy online if you have any concerns or questions about your medication.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
icsUsildedCiprofloxacin
ialisTreatment of infections caused by susceptible anaerobic bacteria. In vitro susceptibility studies of Ciprofloxacin-susceptible bacteria. In vitro against two distinct resistant anaerobic bacteria: ciprofloxacin and nalidixic acid. In-vitro susceptibility of Ciprofloxacin-susceptible bacteria to nalidixic acid: The susceptibility of nalidixic acid-sensitive anaerobic bacteria to Ciprofloxacin is also determined against nalidixic acid. In-vitro susceptibility of Ciprofloxacin-susceptible bacteria to ciprofloxacin: The susceptibility of nalidixic acid-sensitive anaerobic bacteria to ciprofloxacin is also determined against ciprofloxacin. In vitro, the anaerobic bacteria that cause anaerobic bacteria ( Enterobacteriaceae) infections. In vitro, Ciprofloxacin-susceptible bacteria to nalidixic acid: The anaerobic bacteria that cause anaerobic bacteria infections ( Enterobacteriaceae). Ciprofloxacin-susceptible bacteria to nalidixic acid: The anaerobic bacteria that cause anaerobic bacteria infections ( Enterobacteriaceae). Quinolones are an alternative therapy for urinary tract infections caused by susceptible anaerobic bacteria. In vitro, nalidixic acid-resistant nalidixic acid-sensitive bacteria are also quinolone-sensitive.
Oropharyngeal and esophageal strictures
History or risk of QT prolongation; known or suspected of having a direct relationship to the use of Ciprofloxacin or other quinolones. Concomitant use of ciprofloxacin and nalidixic acid.
Ciprofloxacin HCL oral suspension is a prescription medicine for the treatment of bacterial infections caused by susceptible bacteria in the ear, nose, throat, urinary tract, skin, lungs, bones, and joints. Ciprofloxacin HCL oral suspension is used to treat and prevent infections in susceptible bacteria.
Ciprofloxacin HCL oral suspension is a broad-spectrum antibacterial that belongs to the fluoroquinolone class of antibiotics. Ciprofloxacin HCL oral suspension works by killing the bacteria causing the infection. The medicine is usually taken once or twice a day, depending on the infection being treated.
This medication is commonly used to treat skin, bone, joint, or lung infections caused by certain bacteria. It is also used to treat sexually transmitted diseases, such as chlamydia, gonorrhea, syphilis, and malaria. Ciprofloxacin HCL oral suspension is not approved for use in children under the age of 18 years.
It is important to tell your doctor if you are allergic to Ciprofloxacin or other quinolone antibiotics such as fluoroquinolone antibiotics (such as ciprofloxacin and levofloxacin), or any other medicines. You should also tell your doctor if you are currently pregnant or planning to become pregnant. Ciprofloxacin HCL oral suspension may harm your unborn baby. Do not take Ciprofloxacin HCL oral suspension if you are taking or have recently taken an antibiotic such as ciprofloxacin or levofloxacin. Ciprofloxacin HCL oral suspension should not be used during pregnancy or in nursing or when you are pregnant.
The usual dosage of Ciprofloxacin HCL oral suspension depends on the type of infection being treated. For urinary tract infections (UTIs), the dosage is usually 1 gram twice a day for the first few days and then 3 milligrams for the next four days. For respiratory infections, the dosage is usually 1 gram twice a day for the first four days and then 3 milligrams for the next four days.
Ciprofloxacin HCL oral suspension is generally welltolerated. Common side effects include nausea, vomiting, diarrhea, and headache. More serious side effects may include skin rash, liver dysfunction, or an increased risk of blood clots. Serious side effects include prolonged and painful urination, severe allergic reactions, or kidney problems. Ciprofloxacin HCL oral suspension may cause an upset stomach, dizziness, and abnormal vision. If you experience these side effects, stop taking Ciprofloxacin HCL oral suspension and contact your doctor right away.
If you are currently taking or have recently taken an antibiotic such as ciprofloxacin or levofloxacin, you should not take Ciprofloxacin HCL oral suspension. The side effects of ciprofloxacin and levofloxacin can be serious and may require immediate medical attention. Ciprofloxacin HCL oral suspension can cause a serious reaction when combined with certain drugs.
Ciprofloxacin and levofloxacin are both antibiotics used to treat bacterial infections in the body.
Ciprofloxacin HCL oral suspension contains ciprofloxacin. Ciprofloxacin HCL oral suspension is a fluoroquinolone antibiotic. It kills the bacteria causing the infection.
Ciprofloxacin HCL oral suspension inhibits bacterial DNA synthesis by inhibiting DNA gyrase. This allows the bacteria to reproduce and multiply. It does this by stopping the enzyme DNA gyrase from being incorporated.
Ciprofloxacin HCL oral suspension can also be used to treat infections caused by other susceptible bacteria. Ciprofloxacin HCL oral suspension may also be used in combination with antibiotics.
Pietri-McGinley M, et al. Pharmacological action of ciprofloxacin: a review. J Am Med. 2018;53(1):49-52.
Ravikula S, et al. Antimicrobials: a review. Antimicrob Agents. 2017;20(6):e1104..
Korvaniyana S, et al. The influence of fluoroquinolones on the metabolism of ciprofloxacin by the human gut bacteria. J Clin Microbiol. 2020;67(5):738-42.
Nemecke J, et al. The effect of ciprofloxacin on the development and maturation of human intestinal microflora. Int J Clin Microbiol. 2018;20(2):62-68.
Liu G, et al. Effect of ciprofloxacin on gut bacterial composition, immune response, and microbiota in humans: a randomized controlled trial. 2017;57(11):1020-30.
Hsu YW, et al. Ciprofloxacin is a new antibacterial agent with potent antibacterial activity. 2014;55(2):57-64.
Soraya N, et al. Effect of fluoroquinolone antibiotics on the microbiota in patients with urinary tract infections: a randomised double-blind trial. Urology. 2014;55(7):732-40.
Zhang YL, et al. Effect of ciprofloxacin on the growth of bacteria in the human gut. 2017;57(11):1025-35.
Zhang LZ, et al. Ciprofloxacin and the effect of bismuth subsalicylate on gut microbial composition and oxidative stress in the human gut. Infect. Dis. 2017;12(7):1228-41.
Khan N, et al. Effect of fluoroquinolones on the pharmacokinetics of ciprofloxacin in healthy volunteers. Am J Clin Pharmacol. 2018;74(1):1-16.
Ciprofloxacin and the effect of bismuth subsalicylate on gut bacteria in rats: a randomized controlled trial.
Ciprofloxacin and the effect of bismuth subsalicylate on gut bacteria in rats: a randomised double-blind trial.
Mansour S, et al. Ciprofloxacin and the effect of bismuth subsalicylate on the development and maturation of human intestinal microflora.
Gossenberger G, et al. Ciprofloxacin and gut microbiota in humans with urinary tract infections: a systematic review. J Am Soc Nephrol. 2015;3(4):341-52.
Duan JY, et al. 2016;7(3):343-55.
Ciprofloxacin and the effect of bismuth subsalicylate on gut bacterial composition and oxidative stress in the human gut.
The Canadian Patent Office, (CPI) has issued an advisory onThe Canadian Patent Office,a non-inclusive application for the registration of a CIPRO Canadian Registration Number (CRN) for aCIPRO Company Registration Date. TheCIPRO Company Registration Number (CRN) for a CIPRO Company Patent Numberwas issued in February 2022.
The application is currently being considered and, if approved, the CPI will consider the application. As per theCIPRO Company Regulationsof the Canadian Patent Office, the application isnot considered for use by anyone.
The Canadian Patent Office and the Canadian Patent Office’s Office of Innovation are responsible for ensuring that applications are filed in accordance with the
The Canadian Patent Office and the Canadian Patent Office’s Office of Innovation are responsible for ensuring thatthe application for a CIPRO Company Patent Number isto be filed.